Breaking News Instant updates and real-time market news.

AVXS

AveXis

$115.91

-3.69 (-3.09%)

14:21
04/09/18
04/09
14:21
04/09/18
14:21

AveXis upgraded to Neutral from Reduce at Nomura Instinet

Nomura Instinet analyst Christopher Marai upgraded AveXis (AVXS) to Neutral after the company agreed to be acquired by Novartis (NVS) for $218 per share.

AVXS AveXis
$115.91

-3.69 (-3.09%)

04/09/18
JEFF
04/09/18
NO CHANGE
JEFF
Buy
Jefferies ponders other potential suitors for AveXis after Novartis deal
Jefferies analyst Biren Amin asks who else can jump into the mix after AveXis (AVXS) agreed to be acquired by Novartis (NVS) for $218 per share in an all-cash deal. The analyst, who does not expect anti-trust issues to arise with the deal on the table, notes the speculation that Biogen (BIIB) may need to evaluate AveXis at some point. The Novartis deal could be the "trigger that forces it to do so," Amin writes in a research note. Further, the analyst has always felt Roche (RHHBY) could have an interest in AveXis given its development program with RG7916. He points out that AveXis Chairman Dan Welch was the CEO of Intermune when Roche purchased the company in 2014 for $8.3B. AveXis in premarket trading is up 81%, or $94.14, to $210.05.
04/09/18
JEFF
04/09/18
NO CHANGE
JEFF
Jefferies highlights other gene theraphy players after AveXis takeover
Novartis' (NVS) deal to acquire AveXis (AVXS) for $8.7B should remind investors about the ongoing attractiveness within smid-cap biotech, Jefferies analyst Michael Yee tells investors in a research note. Novartis' two large gene therapy deals in four months will lead to a question of "who's next," the analyst adds. Yee says other mid-late stage gene therapy players include Bluebird Bio (BLUE), Spark Therapeutics (ONCE), BioMarin (BMRN), Abeona Therapeutics (ABEO), Regenxbio (RGNX), Nightstar Therapeutics (NITE) and Voyager Therapeutics (VYGR).
04/09/18
WBLR
04/09/18
DOWNGRADE
WBLR
Market Perform
AveXis downgraded to Market Perform from Outperform at William Blair
William Blair analyst Raju Prasad downgraded AveXis (AVXS) to Market Perform after the company reached an agreement to be acquired by Novartis (NVS).
04/09/18
MSCO
04/09/18
DOWNGRADE
MSCO
Equal Weight
AveXis downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst David Lebowitz downgraded AveXis (AVXS) to Equal Weight from Overweight following its announcement of an agreement to be acquired by Novartis (NVS) for $218 per share. He added that the buyout premium AveXis garnered should benefit Regenxbio (RGNX) as well.

TODAY'S FREE FLY STORIES

FB

Facebook

$132.47

0.85 (0.65%)

05:37
11/21/18
11/21
05:37
11/21/18
05:37
Periodicals
Zuckerberg tells CNN stepping down as Facebook chairman 'not the plan' »

In an interview with CNN,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

SPI

SPI Energy

$2.36

0.06 (2.61%)

05:35
11/21/18
11/21
05:35
11/21/18
05:35
Hot Stocks
SPI Energy receives Nasdaq filing extension »

SPI Energy announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQ

iQIYI

$19.08

-0.43 (-2.20%)

, GOOG

Alphabet

$1,026.00

7 (0.69%)

05:28
11/21/18
11/21
05:28
11/21/18
05:28
Hot Stocks
iQIYI announces DRM partnership with Google »

iQIYI (IQ) announced that…

IQ

iQIYI

$19.08

-0.43 (-2.20%)

GOOG

Alphabet

$1,026.00

7 (0.69%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

MRKR

Marker Therapeutics

$6.26

-0.42 (-6.29%)

05:28
11/21/18
11/21
05:28
11/21/18
05:28
Initiation
Marker Therapeutics initiated  »

Marker Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 07

    Dec

BZUN

Baozun

$30.07

-0.98 (-3.16%)

05:26
11/21/18
11/21
05:26
11/21/18
05:26
Earnings
Breaking Earnings news story on Baozun »

Baozun sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BZUN

Baozun

$30.07

-0.98 (-3.16%)

05:25
11/21/18
11/21
05:25
11/21/18
05:25
Earnings
Baozun reports Q3 EPS 13c, consensus 11c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BZUN

Baozun

$30.07

-0.98 (-3.16%)

, LITB

LightInTheBox

$1.10

(0.00%)

05:24
11/21/18
11/21
05:24
11/21/18
05:24
Hot Stocks
Baozun appoints Robin Lu as CFO »

Baozun announced that…

BZUN

Baozun

$30.07

-0.98 (-3.16%)

LITB

LightInTheBox

$1.10

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

ZLAB

Zai Lab

$17.00

-0.2 (-1.16%)

05:23
11/21/18
11/21
05:23
11/21/18
05:23
Initiation
Zai Lab initiated  »

Zai Lab initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAVI

Navient

$10.74

-1.255 (-10.47%)

05:21
11/21/18
11/21
05:21
11/21/18
05:21
Hot Stocks
Navient CEO sends letter to holders in response to AP article »

Navient released the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

TEDU

Tarena

$7.26

-0.995 (-12.06%)

05:21
11/21/18
11/21
05:21
11/21/18
05:21
Downgrade
Tarena rating change  »

Tarena downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABIL

Ability

$2.83

-0.15 (-5.03%)

05:17
11/21/18
11/21
05:17
11/21/18
05:17
Hot Stocks
Ability to acquire supplier of principal cellular interception system »

Ability announced that,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVVY

Indivior

$0.00

(0.00%)

05:16
11/21/18
11/21
05:16
11/21/18
05:16
Downgrade
Indivior rating change  »

Indivior downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFODF

Premier Foods

$0.00

(0.00%)

05:15
11/21/18
11/21
05:15
11/21/18
05:15
Upgrade
Premier Foods rating change  »

Premier Foods upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SE

Sea Limited

$12.18

-0.52 (-4.09%)

05:12
11/21/18
11/21
05:12
11/21/18
05:12
Recommendations
Sea Limited analyst commentary  »

Sea Limited posted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADSK

Autodesk

$122.99

-2.76 (-2.19%)

05:09
11/21/18
11/21
05:09
11/21/18
05:09
Recommendations
Autodesk analyst commentary  »

Autodesk price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 04

    Dec

ANAB

AnaptysBio

$68.73

0.8 (1.18%)

05:03
11/21/18
11/21
05:03
11/21/18
05:03
Initiation
AnaptysBio initiated  »

AnaptysBio initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DXCM

DexCom

$119.89

-1.34 (-1.11%)

, GOOG

Alphabet

$1,026.00

7 (0.69%)

05:01
11/21/18
11/21
05:01
11/21/18
05:01
Hot Stocks
DexCom, Alphabet's Verily amend collaboration and license agreement »

DexCom (DXCM) and Verily,…

DXCM

DexCom

$119.89

-1.34 (-1.11%)

GOOG

Alphabet

$1,026.00

7 (0.69%)

GOOGL

Alphabet Class A

$1,031.22

4.99 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Nov

  • 04

    Dec

  • 03

    Mar

ADI

Analog Devices

$89.12

3.57 (4.17%)

04:55
11/21/18
11/21
04:55
11/21/18
04:55
Recommendations
Analog Devices analyst commentary  »

Analog Devices price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

04:55
11/21/18
11/21
04:55
11/21/18
04:55
General news
Jobless Claims to be reported at 08:30 »

Week of 11/17 Jobless…

ELEZY

Endesa

$0.00

(0.00%)

04:55
11/21/18
11/21
04:55
11/21/18
04:55
Conference/Events
Endesa to hold a webcast »

Strategic plan update…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

04:55
11/21/18
11/21
04:55
11/21/18
04:55
General news
Leading Indicators to be reported at 10:00 »

October Leading…

04:55
11/21/18
11/21
04:55
11/21/18
04:55
General news
Breaking General news story  »

Week of 11/16 MBA…

04:55
11/21/18
11/21
04:55
11/21/18
04:55
General news
Consumer Sentiment Index to be reported at 10:00 »

Consumer Sentiment Index…

04:55
11/21/18
11/21
04:55
11/21/18
04:55
General news
Breaking General news story  »

Week of 11/16 EIA…

04:55
11/21/18
11/21
04:55
11/21/18
04:55
General news
Breaking General news story  »

Week of 11/16 EIA Natural…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.